CARL WALTHER to Cost-Benefit Analysis
This is a "connection" page, showing publications CARL WALTHER has written about Cost-Benefit Analysis.
Connection Strength
0.129
-
The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins. Kidney Int. 2019 07; 96(1):22-25.
Score: 0.129
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.